We are the only hospital federation 100% dedicated to cancer care in France. We defend the unique model of treatment and care that characterises the French Comprehensive Cancer Centres within our netw
Our network places patients at the core of its activities: they are partners throughout their treatment pathway and benefit from comprehensive, personalised and innovative care.
Bringing together more than 25,500 professionals, our network offers an attractive professional framework a to develop the expertise of each professional for the benefit of patients
Our policy of purchasing and access to innovation enables the Centres of our network to access state-of-the-art equipment and innovative treatments, in a responsible way.
Discover the list of information sites on rare cancers (in alphabetical order).
Association "Des étoiles dans la mer, vaincre le glioblastome"
Association supporting patients with glioblastoma, funding research and raising awareness among public opinion.
Association Française des Malades du Myélome Multiple
Association which supports people with multiple myeloma and their families.
Association HNPCC-Lynch
Association which brings together families confronted with Lynch syndrome or HNPCC (Hereditary Non Polyposis Colorectal Cancer), a hereditary predisposition to familial colorectal and uterine cancers.
Association pour la Recherche sur les Tumeurs de Rein (A.R.Tu.R)
Association which supports patients and develops research on kidney tumours.
France Lymphomes Espoir
Association which assists and informs lymphoma patients.
Info sarcomes
Association which aims to develop knowledge of sarcoma and improve their management.
LMC France (Leucémie Myéloïde Chronique)
Association which supports people with chronic myeloid leukaemia, a rare form of leukaemia.
Maladies rares info services
Portal for patients, their families and healthcare professionals.
Rare Cancers Europe (in English)
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda.